C. Helm

发表

Current status and future directions of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer.

C. Helm, 2012, Surgical oncology clinics of North America.

LAPAROSCOPIC MANAGEMENT OF THE ADNEXAL MASS

R. Pasic, C. Helm, 2007 .

Retinoids for preventing the progression of cervical intra-epithelial neoplasia.

D. Lorenz, W. Rising, C. Helm, 2013, The Cochrane database of systematic reviews.

Anti‐inflammatory agents for preventing the progression of cervical intraepithelial neoplasia

C. Helm, Judith L. Wulff, J. L. Wulff, 2008 .

Detection of Cervical Cancer Biomarker Patterns in Blood Plasma and Urine by Differential Scanning Calorimetry and Mass Spectrometry

J. Klein, M. Merchant, J. Chaires, 2014, PloS one.

Laparoscopic surgery for endometrial cancer: increasing body mass index does not impact postoperative complications

S. Rai, D. Metzinger, Jianmin Pan, 2011, Journal of gynecologic oncology.

Ports and complications for intraperitoneal chemotherapy delivery

C. Helm, CW Helm, 2012, BJOG : an international journal of obstetrics and gynaecology.

Differential Expression of CD3ζ Message and Protein in Tumor Infiltrating Lymphocytes from Solid Tumor Specimens and Malignant Ascites from Patients with Ovarian Carcinoma

R. Freedman, A. Wolfson, C. Helm, 2009 .

Differential expression of T-cell CD3-zeta chains in patients with cervical dysplasia before and after treatment

D. Taylor, C. Helm, Ç. Gerçel-Taylor, 2006, International Journal of Gynecologic Cancer.

Hyperthermic intraperitoneal chemotherapy for ovarian cancer: is there a role?

C. Helm, 2015, Journal of gynecologic oncology.

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Ovarian Cancer: World Experience

C. Helm, 2007 .

Retraction of an intraperitoneal chemotherapy port: a case report and literature review

D. Metzinger, L. Parker, C. Helm, 2006, International Journal of Gynecologic Cancer.

Bacterial contamination during abdominal hysterectomy

C. Helm, E. Houang, C. Macdonald, 1986 .

CXCR4 expression in ovarian cancer is associated with peritoneal dissemination

D. Metzinger, M. Ratajczak, R. Edwards, 2004 .

A prospective study of the use of ultrasound in vaginal legal abortion before 20 weeks of pregnancy.

R. Lilford, D. Maxwell, C. Helm, 1986, Journal of obstetrics and gynaecology.

Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia.

C. Helm, J. L. Wulff, Osman M Shariff, 2014, The Cochrane database of systematic reviews.

Techniques of Delivering Hyperthermic Intraperitoneal Chemotherapy

J. Esquivel, P. Sugarbaker, C. Helm, 2007 .

Intraperitoneal cancer therapy

R. Edwards, C. Helm, R. Edwards, 2007 .

Cisplatin plus sodium arsenite and hyperthermia induces pseudo-G1 associated apoptotic cell death in ovarian cancer cells.

C. Muenyi, J. States, Clarisse S Muenyi, 2014, Toxicological sciences : an official journal of the Society of Toxicology.

Diagnosis and Management of Epithelial Ovarian Cancer with Peritoneal Metastases

P. Sugarbaker, C. Helm, C. William Helm, 2014 .

Cytoreduction and intraperitoneal heated chemotherapy for the treatment of endometrial carcinoma recurrent within the peritoneal cavity

D. Metzinger, L. Parker, R. Edwards, 2006, International Journal of Gynecologic Cancer.

Hyperthermic intraperitoneal chemotherapy in ovarian cancer: rationale and clinical data

C. Helm, E. de Bree, 2012, Expert review of anticancer therapy.

Meconium aspiration and fetal acidosis.

C. Helm, R. Beard, 1986, Obstetrics and gynecology.

Differential scanning calorimetry of blood plasma for clinical diagnosis and monitoring.

J. Chaires, N. Garbett, A. Jenson, 2009, Experimental and molecular pathology.

Enhancing the efficacy of cisplatin in ovarian cancer treatment – could arsenic have a role

J. States, C. Helm, J. States, 2009, Journal of ovarian research.

Sodium arsenite ± hyperthermia sensitizes p53-expressing human ovarian cancer cells to cisplatin by modulating platinum-DNA damage responses.

Guy N Brock, T. Fan, C. Muenyi, 2012, Toxicological sciences : an official journal of the Society of Toxicology.

Sodium arsenite and hyperthermia modulate cisplatin-DNA damage responses and enhance platinum accumulation in murine metastatic ovarian cancer xenograft after hyperthermic intraperitoneal chemotherapy (HIPEC)

T. Fan, C. Muenyi, J. States, 2011, Journal of ovarian research.

Uterine activity in the second stage of labour and the effect of epidural analgesia

R. Bates, C. Helm, D. Edmonds, 1985, British journal of obstetrics and gynaecology.

Epidural Analgesia during Labour: Why Does This Increase the Forceps Delivery Rate?

R. Bates, C. Helm, 1985, Journal of the Royal Society of Medicine.

Enhancing adherence following abnormal Pap smears among low-income minority women: a preventive telephone counseling strategy.

Suzanne M. Miller, C. Lerman, E. Hernandez, 1997, Journal of the National Cancer Institute.

Substantial proportions of identical beta-chain T-cell receptor transcripts are present in epithelial ovarian carcinoma tumors.

J. Gaughan, M. Radu, R. Freedman, 2005, Cellular immunology.

Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer

R. Bristow, M. Deraco, S. Kusamura, 2008, Journal of surgical oncology.

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: First Report of the HYPER-O Registry

S. Rai, D. Metzinger, D. Bartlett, 2009, International Journal of Gynecologic Cancer.

Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia.

C. Helm, Osman M Shariff, S. Grabosch, 2014, The Cochrane database of systematic reviews.

Cytoreductive Surgery and Normothermic Intraperitoneal Chemotherapy for Signet Ring Cell Appendiceal Adenocarcinoma With Peritoneal Metastases in the Setting of Cirrhosis

J. Lai, E. Hsueh, C. Helm, 2018, Gastroenterology research.

Adenocarcinoma of the uterine cervix.

L. Kilgore, C. Helm, 1990, Clinical obstetrics and gynecology.

Division of the pont hepatique of the liver in cytoreductive surgery for peritoneal malignancy.

C. Helm, J. Veerapong, H. Solomon, 2013, Gynecologic oncology.

Resection of tumor from the supragastric lesser sac with peritonectomy.

C. Helm, J. Veerapong, H. Solomon, 2012, Gynecologic oncology.

Systems approach to identify environmental exposures contributing to organ-specific carcinogenesis.

J. States, M. Ouyang, C. Helm, 2014, Cancer epidemiology.

Substantial proportions of identical beta-chain T-cell receptor transcripts are present in epithelial ovarian carcinoma tumors.

J. Gaughan, M. Radu, R. Freedman, 2005, Cellular immunology.

SECONDARY SURGICAL CYTOREDUCTION AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (SSC-HIPEC) FOR RECURRENT OVARIAN AND ENDOMETRIAL CANCER

D. Metzinger, C. Helm, R. Edwards, 2004, International Journal of Gynecologic Cancer.